Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Adamis Pharmaceuticals Corp (NASDAQ:ADMP)

2.84
BATS BZX Real-Time Price
As of 2:10pm ET
 -0.10 / -3.40%
Today’s Change
2.50
Today|||52-Week Range
10.98
-47.41%
Year-to-Date
A Backlash Materializes Against Soaring EpiPen Prices
Aug 23 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close2.94
Today’s open3.09
Day’s range2.80 - 3.09
Volume52,829
Average volume (3 months)340,024
Market cap$61.4M
Dividend yield--
Data as of 2:10pm ET, 08/24/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.24

Competitors

 Today’s
change
Today’s
% change
CRMECardiome Pharma Corp-0.03-0.97%
NVETNexvet Biopharma plc-0.25-5.02%
PTXPernix Therapeutics ...-0.01-1.84%
DMPIDelMar Pharmaceutica...+0.26+4.01%
Data as of 2:09pm ET, 08/24/2016

Financials

Last reporting dateAugust 24, 2016
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$13.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Dennis J. Carlo
Vice President-
Operations
Karen K. Daniels
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs